483
Regeneron Pharmaceuticals IncRegeneron Pharmaceuticals Inc – FDA 483, Mar 22, 2024
Record Details
An FDA inspection of Regeneron Pharmaceuticals Inc. in Rensselaer, NY, identified a significant deficiency in their quality system. The firm lacked written procedures for production and process controls, specifically concerning a Process Performance Qualification study for drug product formulation. This indicates a failure to ensure drug products consistently meet identity, strength, quality, and purity standards.
View Company Profile
ID · 42489734-29a2-46d5-96fb-7559354403d0
Other documents for Regeneron Pharmaceuticals Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.